There are high rates of co-occurring posttraumatic stress disorder (PTSD) among patients receiving treatment for substance use disorder (SUD). PTSD and SUD should be treated simultaneously, but adults in SUD treatment are often not assessed for PTSD nor offered PTSD-based interventions. One of the reasons for reluctance in offering trauma focused treatment is increased risk of drop out. PTSD and related emotion dysregulation are related to elevated psychological burden, higher dropout rates and increased risk of relapse. this is a feasibility study, where the plan is to integrate a combination of Dialectical Behaviour Therapy for Substance Use Disorder (DBT-SUD skills) a therapy targeting difficulties in emotion regulation and Narrative Exposure Therapy (NET) a trauma focused therapy, for patients with co-occurring PTSD symptoms into standard SUD treatment . The plan is to assess its potential benefits by assessing whether adding this combination to standard SUD treatment is relevant, feasible, acceptable, and safe. Treatment outcomes are 1) Prevalence of PTSD, suicidal behaviour, and self-harm, as well as the severity of difficulties in emotion regulation and emotional avoidance among patients (N approx. = 100) in inpatient treatment for SUD. 2) Change post-treatment and at 3 and 12 months follow up, from baseline in PTSD symptom severity, depressive symptoms, emotion regulation, emotion avoidance, and experience of shame. 3) Rates of dropout and relapse compared to previous rates. This project can increase knowledge about psychological mechanisms in co-occurring PTSD and SUD and improve the quality of treatment for this vulnerable patient population.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
The intervention is relevant - prevalence of PTSD /SUP PTSD.
Timeframe: One time assessment 5 weeks after admission to treatment
The intervention is relevant - prevalence of traumatic experiences.
Timeframe: One time assessment 5 weeks after admission to treatment
The intervention is relevant - The severitiy of difficulties in emotion regulation.
Timeframe: One time assessment 5 weeks after admission to treatment
The intervention is feasible, accepted and safe - The dropout rate from treatment.
Timeframe: From treatment start to compleation up to 9 months.
The intervention is safe - Suicide behaviour while in treatment.
Timeframe: From treatment start to compleation up to 9 months.
The intervention is safe - Self-harm behaviour while in treatment.
Timeframe: From treatment start to compleation up to 9 months.
The intervention is accepted - participation in DBT-SUD skills sessions.
Timeframe: From treatment start to compleation up to 9 months.
The intervention is feasible and accepted - Objective experience of treatment.
Timeframe: From treatment start to treatment compleation up to 9 months.